News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
News
Business
Drexel University’s New Breast Cancer Screening Device is Licensed by UE LifeSciences
December 1, 2010
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
Bioportfolio -- A new device may enable breast cancer screening and cancer detection in populations where mammography is not widely available or successful, including women in developing countries, and those under the age of 40.
Twitter
LinkedIn
Facebook
Email
Print
Alliances
Drexel University
MORE ON THIS TOPIC
Mergers & acquisitions
BioNTech Swallows Vaccine Rival CureVac in $1.25B All-Stock Acquisition
June 12, 2025
·
3 min read
·
Tristan Manalac
Layoffs
Genentech Lays Off 143 Employees in South San Francisco Reshuffle
June 11, 2025
·
1 min read
·
Dan Samorodnitsky
Deals
BMS Expands Radiopharma Presence With $1.35B Biobucks Deal for Philochem
June 11, 2025
·
2 min read
·
Tristan Manalac
Funding
SpliceBio Nabs $135 Million Series B To Advance Protein Splicing Medicines
June 11, 2025
·
2 min read
·
Dan Samorodnitsky